FuturHealth Offers Users Complimentary Access to Apple Fitness+ for Movement and Motivation
This offer underscores FuturHealth's commitment to empowering members with a comprehensive toolkit that supports sustainable, personalized weight loss journeys, whether with medication, nutrition, fitness, or a combination of all three.
"Our top priority has always been to help people on a weight loss journey experience real, long-lasting results through holistic lifestyle changes and personalized support," said Luke Mahoney, co-founder and CEO of FuturHealth. "With this Fitness+ offer, users can tap into thousands of workouts and meditations—wherever and whenever they choose—at no extra cost."
Fitness+ offers users access to thousands of workouts and meditations in 4K Ultra High Definition on iPhone, iPad and Apple TV, ranging from 5 to 45 minutes across 12 different types including Strength, HIIT, Treadmill, Rowing, Cycling, Yoga, and more. All it takes is an iPhone to get started— and with Apple Watch, users can unlock even more motivation through personalized, real-time metrics right onscreen. Fitness+ workouts feature energizing music playlists by today's top artists all led by a diverse and inclusive team of trainers that can be done anytime, anywhere. Fitness+ also offers inspiring audio experiences including Time to Walk and Time to Run.
Users can access the Fitness+ offer by simply tapping on the Apple Fitness+ module on the home screen in the FuturHealth app.
This announcement follows a series of significant milestones for the company. This year alone, FuturHealth launched Affirm's flexible payment options for members, partnered with Valisure to ensure the highest quality and safety standards for weight-loss medications, and released compelling efficacy data showing that combining the FuturHealth Program with weight-loss treatments significantly enhances weight loss outcomes compared to medication alone.
For more information about FuturHealth's innovative approach, visit www.fh.co.
About FuturHealth:FuturHealth is your partner in weight loss, providing personalized guidance designed to work with your everyday life. Together with a team of doctors, dietitians, and weight-loss experts, we combine scientifically-proven medications with clinically-crafted, expertly-curated meals for quick, easy, effective, and affordable wins. Founded with a mission to create a holistic and personalized alternative to traditional, one-size-fits-all weight-loss solutions, we meet each person where they are on their unique journey, empowering them to confidently take control of their well-being at every step of the way. With a network of 350+ providers across 48 states, FuturHealth has transformed the lives of over 1.5 million patients and counting. In under a year, it has achieved an extraordinary 980% growth in active patients and facilitated over 6 billion online interactions.
View original content to download multimedia:https://www.prnewswire.com/news-releases/futurhealth-offers-users-complimentary-access-to-apple-fitness-for-movement-and-motivation-302525407.html
SOURCE FuturHealth
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Tom's Guide
14 minutes ago
- Tom's Guide
Apple brings back blood oxygen monitoring to latest Apple Watches — but there's a catch
Starting today, blood oxygen monitoring is returning to the Apple Watch for users in the US. Apple is rolling out a software update that enables a redesigned version of the feature on the Apple Watch Series 9, 10, and Ultra 2. This follows the import ban imposed by the International Trade Commission, which has prevented users in the U.S. from accessing this data for over a year. Users in the U.S. who have one of the newer Apple watches will need to update their watch to WatchOS 11.6.1 today. However, there's a slight catch: you'll also need to update your connected iPhone to iOS 18.6.1, as to get around the import ban, the blood oxygen data will only be viewable on your iPhone. Following the update, the Apple Watch will measure blood oxygen, and you'll be able to view it in the Health app of your iPhone under the Respiratory section. This redesign only covers Apple Watches sold after the ITC import ban was put in place on January 17, 2024. Older models, or watches sold outside the U.S., all have the original blood oxygen feature, and will not be affected. This redesign only covers Apple Watches sold after the ITC import ban was put in place on January 17, 2024. Blood oxygen monitoring was first introduced with the Apple Watch Series 6 in 2020. It tells you the percentage of oxygen in your blood at any given moment. For most healthy individuals, the blood oxygen saturation level will be around 95-100%. If it's below this, it might be a sign of a health condition. Medical tech company Masimo previously sued Apple, claiming the blood oxygen feature infringed on its pulse oximetry patents. In 2023, the US International Trade Commission ruled against Apple, leading to Apple disabling the feature on the Apple Watch Series 9 and Ultra 2 in the US to avoid a ban. This news comes ahead of the rumored release of the Apple Watch 11 and Apple Watch Ultra 3 next month, both of which are likely to also have a blood oxygen sensor. You can read Apple's full statement about blood oxygen returning to Apple Watch here. Get instant access to breaking news, the hottest reviews, great deals and helpful tips. Follow Tom's Guide on Google News to get our up-to-date news, how-tos, and reviews in your feeds. Make sure to click the Follow button.
CNBC
15 minutes ago
- CNBC
Apple Watch getting redesigned blood oxygen feature following legal dispute
Apple on Thursday announced a redesigned blood oxygen feature for some Apple Watch users, following a years-long intellectual property dispute over the capability. Apple said the redesigned feature is coming to some Apple Watch Series 9, Series 10, and Apple Watch Ultra 2 users on Thursday. The update was possible because of a recent U.S. Customs ruling, the company said. In 2023, the International Trade Commission found that Apple's blood oxygen sensors infringed on intellectual property from Masimo, a medical technology company. Apple paused the sale of some of its watches and began selling modified versions of the wearables without the blood oxygen feature. "Apple's teams work tirelessly to create products and services that empower users with industry-leading health, wellness, and safety features that are grounded in science and have privacy at the core," the company said in a release announcing the feature rollout. CNBC has reached out to Masimo for comment. Users who do not currently have the feature will be able to access it by updating their iPhone to iOS 18.6.1 and their Apple Watch to watchOS 11.6.1, Apple said. Users will be able to see their results in the Respiratory section of the Health app. Apple has been pushing deeper into health care in recent years. The company recently released a sleep apnea detection feature for Apple Watch users and hearing health features for its AirPods headphones. In February, Apple launched its first major health study in five years.
CNBC
15 minutes ago
- CNBC
Move over Nvidia, UBS says this chip stock will be the fastest-growing over the next few years
Little-known chipmaker SiTime could be the next big name in the semiconductor universe, according to UBS. Analyst Timothy Arcuri initiated coverage of the company with a buy rating and $260 price target, which indicates about 20% upside ahead. Arcuri thinks SiTime is a leading precision timing company, which in the semiconductor industry refers to devices that generate and control signals needed for electronic circuits. These are vital for the operation, data transmission and other actions in semis. "With new silicon based solutions, SiTime is disrupting the timing market – the "heartbeat" of the electronics world – and we believe will be one of the fastest growing companies in all of semis over the next few years, led in part by AI," Arcuri said in a note to clients. "SiTime's leadership position within the MEMS timing market has led to design wins at Apple and NVDA that we believe are catalysts for 36%/30% Y/Y total revenue growth in CY26/CY27e, above Street consensus by 11%/3%." According to Arcuri, one of SiTime's biggest growth opportunities should come from its partnership with Apple. Apple this year made SiTime its exclusive supplier of micro-electro-mechanical systems, oscillators for its in-house modem as the iPhone maker replaced traditional quartz crystal oscillators. Unlike quartz crystal oscillators, MEMS are smaller, more energy-efficient and precise oscillators that can be integrated onto a chip. It's "an opportunity so big that we believe it alone could account for nearly all of the Street's incremental revenue through 2026," he said, referring to the Apple partnership. "SiTime has become the only one-stop shop MEMS timing supplier across the industry capable of addressing system-level clocking applications and is unique in its ability to bring together MEMS/analog/subsystems expertise to build timing systems that do not exist today." SiTime's stock rallied earlier this year on the inclusion of its oscillators in Apple's iPhone 16e. The company's oscillators are also in other Apple products, such as the Apple Pencil Pro. Moreover, Arcuri sees SiTime as a standout artificial intelligence play with room to grow. "In addition to a strong and growing AAPL position, it is also unique among peers in its market cap range given its very high leverage to AI, which we estimate could be pushing 35% of revenue by 2027. We see this year's 40% revenue growth continuing at least through 2026 and likely beyond as it grows into a large served market relative to its current size," the analyst said. SITime isn't widely covered, but most who do are bullish. LSEG data shows that five of the seven analysts covering the stock rate it a buy or strong buy.
